Literature DB >> 22886823

Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.

Tong Liu1, Xianyu Zhang, Ming Shang, Youxue Zhang, Bingshu Xia, Ming Niu, Yang Liu, Da Pang.   

Abstract

BACKGROUND: Among the different types of breast cancer, basal-like breast cancer (BLBC) has an extremely poor prognosis due to its high rate of recurrence and metastasis. The present study aimed to investigate the correlation between the expression of Slug, E-cadherin, and vimentin, and the clinicopathological characteristics and prognosis of patients with BLBC. We further inferred from these findings whether Slug leads to a poor prognosis in patients with BLBC through epithelial-mesenchymal transition (EMT).
METHODS: Immunohistochemistry was performed for 441 patients with breast cancer to determine the expression levels of Slug, E-cadherin, and vimentin. The correlation between protein expression and clinicopathological characteristics of patients with BLBC was evaluated, and these patients were followed up to determine survival rate.
RESULTS: High Slug and low E-cadherin expression in BLBC patients closely correlated with histological grade, lymph node metastasis, tumor-node-metastasis (TNM) stage, and lymphatic vessel metastasis. Survival analysis revealed that the poor prognosis of BLBC is associated with TNM stage, high Slug and vimentin expression, and low E-cadherin levels.
CONCLUSIONS: High Slug expression is closely correlated with poor prognosis in patients with BLBC. We speculate that this may be attributed to the involvement of Slug in the EMT of BLBC.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886823     DOI: 10.1002/jso.23240

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  48 in total

1.  Expression of E-cadherin and vimentin in oral squamous cell carcinoma.

Authors:  Jingping Zhou; Detao Tao; Qing Xu; Zhenlin Gao; Daofang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.

Authors:  Tal Leibovich-Rivkin; Yulia Liubomirski; Biana Bernstein; Tsipi Meshel; Adit Ben-Baruch
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 3.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Authors:  Ping Lu; Shai White-Gilbertson; Rose Nganga; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2019-03-05       Impact factor: 4.742

5.  Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.

Authors:  Z-G Shi; S-Q Li; Z-J Li; X-J Zhu; P Xu; G Liu
Journal:  Clin Transl Oncol       Date:  2014-07-16       Impact factor: 3.405

6.  Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.

Authors:  Aleksandra Markiewicz; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Hanna Majewska; Jolanta Szade; Anna J Żaczek
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

Review 7.  Genomic profiling in triple-negative breast cancer.

Authors:  Cornelia Liedtke; Christof Bernemann; Ludwig Kiesel; Achim Rody
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

Review 8.  SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Authors:  Sarah Phillips; Charlotte Kuperwasser
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

9.  Coexpression of FOXK1 and vimentin promotes EMT, migration, and invasion in gastric cancer cells.

Authors:  Hui Zhang; Xiaosheng Wu; Yizhi Xiao; Liqing Wu; Ying Peng; Weimei Tang; Guangnan Liu; Yong Sun; Jing Wang; Huiqiong Zhu; Mengwei Liu; Wenjing Zhang; Weiyu Dai; Ping Jiang; Aimin Li; Guoxin Li; Li Xiang; Side Liu; Jide Wang
Journal:  J Mol Med (Berl)       Date:  2018-11-27       Impact factor: 4.599

10.  Prognostic significance of HOXD13 expression in human breast cancer.

Authors:  Zhen-Bin Zhong; Ming Shan; Cheng Qian; Tong Liu; Qing-Yu Shi; Ji Wang; Yan Liu; Yang Liu; Yuan-Xi Huang; Da Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.